GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seoul Pharma Co Ltd (XKRX:018680) » Definitions » Shiller PE Ratio

Seoul Pharma Co (XKRX:018680) Shiller PE Ratio : (As of May. 11, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Seoul Pharma Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Seoul Pharma Co Shiller PE Ratio Historical Data

The historical data trend for Seoul Pharma Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seoul Pharma Co Shiller PE Ratio Chart

Seoul Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Seoul Pharma Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Seoul Pharma Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Seoul Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seoul Pharma Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Seoul Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Seoul Pharma Co's Shiller PE Ratio falls into.


;
;

Seoul Pharma Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Seoul Pharma Co's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Seoul Pharma Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=57/121.1352*121.1352
=57.000

Current CPI (Dec. 2024) = 121.1352.

Seoul Pharma Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 29.000 99.721 35.228
201506 -3.000 100.051 -3.632
201509 -150.000 100.111 -181.502
201512 14.000 100.220 16.922
201603 -34.000 100.561 -40.956
201606 -95.000 100.791 -114.176
201609 74.000 101.461 88.349
201612 -562.000 101.561 -670.314
201703 71.000 102.851 83.622
201706 -126.000 102.611 -148.746
201709 -179.000 103.491 -209.519
201712 -1,105.000 102.991 -1,299.673
201803 -46.000 104.101 -53.527
201806 -124.000 104.130 -144.250
201809 -281.000 105.651 -322.185
201812 -450.000 104.351 -522.381
201903 -24.000 104.491 -27.823
201906 52.000 104.881 60.059
201909 98.000 105.200 112.844
201912 -284.839 105.121 -328.231
202003 -302.000 105.354 -347.237
202006 -48.000 105.112 -55.317
202009 909.000 106.198 1,036.859
202012 -718.000 105.765 -822.340
202103 -281.000 107.357 -317.063
202106 -156.000 107.579 -175.658
202109 -100.000 108.759 -111.379
202112 -599.000 109.676 -661.582
202203 -26.000 111.848 -28.159
202206 -4.000 114.072 -4.248
202209 68.000 114.715 71.806
202212 54.000 115.179 56.792
202303 299.000 116.507 310.877
202306 7.000 117.182 7.236
202309 -37.000 118.964 -37.675
202312 33.000 118.837 33.638
202403 51.000 120.123 51.430
202406 23.000 120.007 23.216
202409 15.000 120.861 15.034
202412 57.000 121.135 57.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Seoul Pharma Co  (XKRX:018680) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Seoul Pharma Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Seoul Pharma Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Seoul Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
21, Banpo-daero, Seocho-gu, Seoul, KOR, 06710
Seoul Pharma Co Ltd is engaged in manufacturing and distribution of pharmaceuticals products in South Korea. Its products portfolio consists of drugs for the cardiovascular system, respiratory system, and digestive system, drugs for hypertension, antipyretics, drugs for skin disease, drugs for a cough as well as ointments, among others.

Seoul Pharma Co Headlines

No Headlines